IOVA — Iovance Biotherapeutics, Inc. - Common Stock
Session close: $9.56. Regular-session share volume: 46,209,051. Change from previous close: -35.45%.
News sources
Company news Iovance Biotherapeutics Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for mNSCLC · Company news Iovance Biotherapeutics (IOVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? · Company news Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) · Company news Iovance Biotherapeutics Announced Updated Results From Cohorts 1 And 2 Of Its Phase 2 IOV-LUN-202 Trial; 24.6% Objective Response Rate In 69 Patients With Non-Squamous mNSCLC, Consistent With Previously Reported Results · Company news Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy · Company news Melanoma Trial Results Could Be A Game Changer For Iovance Biotherapeutics (IOVA)